Inventor · disambiguated record
Tino Dyhring
Also filed as: DYHRING TINO
13 granted patents·26 pending applications·39 citations·filing 2006–2020
86Inventor score
Top patents by PatentIndex Score
39 records- 0192US7750011B2Diazabicyclic aryl derivatives and their medical useNEUROSEARCH AS·Filed 2006·Granted Jul 6, 2010·23 cites·16 claims
- 0288US7910578B28,10-diaza-bicyclo[4.3.1]decane derivatives and their medical useNEUROSEARCH AS·Filed 2007·Granted Mar 22, 2011·14 cites·10 claims
- 0371US7662812B2Diazabicyclic aryl derivatives and their use as chinolinergic ligands at nicotinic acetylcholine receptorsNEUROSEARCH AS·Filed 2006·Granted Feb 16, 2010·1 cites·14 claims
- 0468US8110588B21,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptorsNARDI ANTONIO·Filed 2008·Granted Feb 7, 2012·1 cites·9 claims
- 0560US8158619B21,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical usePETERS DAN·Filed 2007·Granted Apr 17, 2012·0 cites·8 claims
- 0658US8372832B21,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical useNEUROSEARCH AS·Filed 2012·Granted Feb 12, 2013·0 cites·5 claims
- 0758US2022143014A1Selective Agonist Of Alpha6 Containing nAChRsGLORIANA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0858US2018311238A1Selective Agonist Of a6 Containing nAChRsSANIONA AS·Filed 2018·Application pending·0 cites
- 0953US2011263651A1Novel piperidine-butyramide derivatives and their use as monoamine neurotransmitter re-uptake inhibitorsNEUROSEARCH AS·Filed 2009·Application pending·0 cites
- 1052US11396510B2GABAA receptor ligandSANIONA AS·Filed 2019·Granted Jul 26, 2022·0 cites·11 claims
- 1152US8343960B21,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical useNEUROSEARCH AS·Filed 2008·Granted Jan 1, 2013·0 cites·8 claims
- 1252US2011263577A1Novel oxadiazolyl-diazabicyclononane derivatives and their medical useNEUROSEARCH AS·Filed 2009·Application pending·0 cites
- 1352US2011257161A1Novel diaza-bicyclononyl-phenyl derivatives and their medical useNEUROSEARCH AS·Filed 2009·Application pending·0 cites
- 1451US7935695B21,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligandsNEUROSEARCH AS·Filed 2008·Granted May 3, 2011·0 cites·3 claims
- 1551US2011112078A1Novel oxadiazolyl-diazabicyclononane derivatives and their medical useNEUROSEARCH AS·Filed 2009·Application pending·0 cites
- 1651US2011207773A1Novel phenyl-quinoline-carboxylic acid pyridine derivatives useful as modulators of nicotinic acetylcholine receptorsNEUROSEARCH AS·Filed 2009·Application pending·0 cites
- 1751US2011112119A1Azabicyclooctyl-quinazolone derivatives useful as nicotinic acetylcholine receptor modulatorsNEUROSEARCH AS·Filed 2009·Application pending·0 cites
- 1850US2010305108A1Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical useNEUROSEARCH AS·Filed 2008·Application pending·0 cites
- 1950US2010292334A1N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptorsNEUROSEARCH AS·Filed 2008·Application pending·0 cites
- 2050US2011046118A1Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical useNEUROSEARCH AS·Filed 2008·Application pending·0 cites
- 2150US2011118268A1Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulatorsPETERS DAN·Filed 2009·Application pending·0 cites
- 2249US2010286128A11,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine-receptor ligandsPETERS DAN·Filed 2008·Application pending·0 cites
- 2349US2010280015A1Noval 1,4-diaza-biclo[3.2.2]nonyl oxadiazolyl derivatives useful as nicotinic acetylcholine receptor ligandsNEUROSEARCH AS·Filed 2008·Application pending·0 cites
- 2448US8101649B2N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptorsNARDI ANTONIO·Filed 2008·Granted Jan 24, 2012·0 cites·11 claims
- 2547US8173658B2Diazabicycylic aryl derivatives and their medical usePETERS DAN·Filed 2006·Granted May 8, 2012·0 cites·13 claims
- 2646US8946412B2Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulatorsPETERS DAN·Filed 2010·Granted Feb 3, 2015·0 cites·5 claims
- 2746US2010227869A1Enantiopure quinuclidinyloxy pyridazines and their use as nicotinic acetylcholine receptor ligandsPETERS DAN·Filed 2007·Application pending·0 cites
- 2846US2009118265A1Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical usePETERS DAN·Filed 2007·Application pending·0 cites
- 2946US2009186880A1Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical usePETERS DAN·Filed 2007·Application pending·0 cites
- 3045US2009075983A1Novel Diazabicycloalkane Derivatives and Their Medical UsePETERS DAN·Filed 2007·Application pending·0 cites
- 3144US2010249165A1Pdz domain modulatorsUNIV COPENHAGEN·Filed 2008·Application pending·0 cites
- 3243US2009291973A1Novel Quinazoline Derivatives and Their Medical UseNEUROSEARCH AS·Filed 2006·Application pending·0 cites
- 3340US2009036473A1Novel quinazolinone derivatives and their medical useBROWN WILLIAM DALBY·Filed 2007·Application pending·0 cites
- 3438US8778928B2Indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical usePETERS DAN·Filed 2010·Granted Jul 15, 2014·0 cites·5 claims
- 3536US2012309792A1Tetrazole derivatives as nicotinic acetylcholine receptor modulatorsPETERS DAN·Filed 2010·Application pending·0 cites
- 3635US2012028968A1Novel dibenzofuranyl-oxadiazolyl-diazabicyclononane derivatives and their medical usePETERS DAN·Filed 2010·Application pending·0 cites
- 3735US2012238553A1Novel benzodioxolyl-oxadiazolyl-diazabicyclononane derivatives and their medical usePETERS DAN·Filed 2010·Application pending·0 cites
- 3835US2012071469A1Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulatorsPETERS DAN·Filed 2010·Application pending·0 cites
- 3935US2012028967A1Novel diaza-bicyclononyl-pyrimidinyl derivatives and their medical usePETERS DAN·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →